Research resources
This page contains research resources related to developing vaccine studies and therapeutics and other research resources below. Follow the development of the various SARS-COV-2 vaccines with the Coronavirus Vaccine Tracker managed by The New York Times.
- Go to therapeutics.
- Go to vaccine studies.
- Go to other research resources.
Research resources: Therapeutics
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
Monoclonal Antibody Therapy
Monoclonal Antibody Therapeutics: How to Operationalize mAB Therapy at Your Facility (November 25, 2020)
COVID-19 Therapeutics (November 18, 2020)
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Remdesivir for the Treatment of Covid-19 — Final Report
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
Remdesivir for the Treatment of Covid-19 — Preliminary Report
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Mild/Moderate 2019-nCoV Remdesivir RCT
Severe 2019-nCoV Remdesivir RCT
Adaptive COVID-19 Treatment Trial (ACTT)
Vaccine Studies:
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial
COVID-19 Vaccine Comparison Chart
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination
Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
SARS-CoV-2 Infection after Vaccination in Health Care Workers in California
BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults...
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years...
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV...
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine...
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report...
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older...
Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)
Other Research resources:
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Nextstrain - Novel coronavirus (2019-nCoV) situation reports and latest data and analysis
Nextstrain - Genetic diversity of betacoronaviruses including novel coronavirus from Wuhan
Nextstrain - Genomic epidemiology of novel coronavirus (nCoV)
Nextstrain - Phylogeny of SARS-like betacoronaviruses including novel coronavirus from Wuhan
